Ghada Gamal, M. Shehata, Shiem El-Sherry
{"title":"CpG-ODN(Toll样受体21激动剂)作为肉鸡新城疫疫苗佐剂的效果","authors":"Ghada Gamal, M. Shehata, Shiem El-Sherry","doi":"10.21608/svu.2021.79758.1129","DOIUrl":null,"url":null,"abstract":"DOI: 10.21608/svu.2021.79758.1129 Received: June 8, 2021 Accepted: August 30, 2021 Published: September 30, 2021 *Corresponding Authors Shiem M. El-Sherry E-mail: shiemelsherry@vet.au.edu.eg Citation: Gamal et al., The effect of CpG-ODN (Toll-like receptor 21 agonist) as an adjuvant for Newcastle disease vaccination in broiler chicken. SVU-IJVS 2021, 4 (3): 94-102. Copyright: © Gamal et al. This is an open access article distributed under the terms of the creative common attribution license, which permits unrestricted use, distribution and reproduction in any medium provided the original author and source are created. Competing interest: The authors have declared that no competing interest exists. Abstract","PeriodicalId":22190,"journal":{"name":"SVU-International Journal of Veterinary Sciences","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2021-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"The effect of CpG-ODN (Toll-like receptor 21 agonist) as an adjuvant for Newcastle disease vaccination in broiler chicken\",\"authors\":\"Ghada Gamal, M. Shehata, Shiem El-Sherry\",\"doi\":\"10.21608/svu.2021.79758.1129\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"DOI: 10.21608/svu.2021.79758.1129 Received: June 8, 2021 Accepted: August 30, 2021 Published: September 30, 2021 *Corresponding Authors Shiem M. El-Sherry E-mail: shiemelsherry@vet.au.edu.eg Citation: Gamal et al., The effect of CpG-ODN (Toll-like receptor 21 agonist) as an adjuvant for Newcastle disease vaccination in broiler chicken. SVU-IJVS 2021, 4 (3): 94-102. Copyright: © Gamal et al. This is an open access article distributed under the terms of the creative common attribution license, which permits unrestricted use, distribution and reproduction in any medium provided the original author and source are created. Competing interest: The authors have declared that no competing interest exists. Abstract\",\"PeriodicalId\":22190,\"journal\":{\"name\":\"SVU-International Journal of Veterinary Sciences\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2021-07-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"SVU-International Journal of Veterinary Sciences\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.21608/svu.2021.79758.1129\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"SVU-International Journal of Veterinary Sciences","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.21608/svu.2021.79758.1129","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
The effect of CpG-ODN (Toll-like receptor 21 agonist) as an adjuvant for Newcastle disease vaccination in broiler chicken
DOI: 10.21608/svu.2021.79758.1129 Received: June 8, 2021 Accepted: August 30, 2021 Published: September 30, 2021 *Corresponding Authors Shiem M. El-Sherry E-mail: shiemelsherry@vet.au.edu.eg Citation: Gamal et al., The effect of CpG-ODN (Toll-like receptor 21 agonist) as an adjuvant for Newcastle disease vaccination in broiler chicken. SVU-IJVS 2021, 4 (3): 94-102. Copyright: © Gamal et al. This is an open access article distributed under the terms of the creative common attribution license, which permits unrestricted use, distribution and reproduction in any medium provided the original author and source are created. Competing interest: The authors have declared that no competing interest exists. Abstract